| ADAM17 | ADAM Metallopeptidase Domain 17 |
| ADMET | Absorption–Distribution–Metabolism–Excretion–Toxicity |
| AGR2 | Anterior gradient protein two homolog |
| Akt | Protein kinase B |
| APC | Anaphase-Promoting Complex |
| Arf/CDKN2A | Cyclin-Dependent Kinase Inhibitor 2A |
| ATM | Ataxia telangiectasia |
| BC | Breast cancer |
| Bcl-2 | B-Cell Lymphoma 2 |
| BRCA2 | Breast cancer 2 |
| Cdc25 | Cell division cycle 25 |
| CDK | Cyclin-Dependent Kinase |
| CDH1 | Cdc20 homolog 1 |
| CENP | Centromere Protein |
| CHK2 | Checkpoint kinase 2 |
| CISR | Cisplatin-resistant |
| CREB | cAMP-Response Element Binding Protein |
| CTCF | CCCTC-Binding Factor |
| CTLA4 | Cytotoxic T-lymphocyte-associated protein 4 |
| DBD | DNA-binding domain |
| DNA | Deoxyribonucleic acid |
| DUB | Deubiquitinating enzyme |
| E2F | Early region 2 binding factor |
| E2F1 | Early region 2 binding factor 1 |
| E3 Ligase | E3 ubiquitin–protein ligase |
| eEF2K | Eukaryotic elongation factor 2 kinase |
| EMT | epithelial–mesenchymal transition |
| ERβ1/EGFR | ErbB-1, also named epidermal growth factor receptor |
| ERK | extracellular signal-regulated kinase |
| ER | Estrogen |
| FDA | Food and Drug Administration |
| FDI-6 | Forkhead Domain Inhibitor-6 |
| FHRE | Forkhead elements |
| FOX | Forkhead box |
| FOXM1 | Forkhead box M1 |
| FT-IR | Fourier transform infrared spectroscopy |
| GATA3 | GATA Binding Protein 3 |
| GBM | Glioblastoma multiforme |
| GLI1 | Glioma-Associated Oncogene Homolog 1 |
| H | Histidine |
| HCC | Hepatocellular carcinoma |
| HER2 | Human epidermal growth factor receptor 2 |
| HGF | Hepatocyte growth factor receptor |
| HH | Hedgehog |
| HIF1α | Hypoxia-Inducible Factor 1 alpha |
| ITGB1 | Integrin subunit beta 1 |
| IPO | Importin-7 |
| JNK | Jun N-terminal kinase |
| KIF20A | Kinesin family member 20 |
| LC3 | Microtubule Associated Protein 1 Light Chain 3 Alpha |
| LC-MS | Liquid chromatography–mass spectrometry |
| lncRNAs | Long noncoding RNAs |
| MAPK | Mitogen-activated protein kinase |
| MCF7 | Michigan Cancer Foundation-7 |
| Mcl-1 | Myeloid Cell Leukemia 1 |
| MD simulation | Molecular dynamics simulation |
| MELK | Maternal embryonic leucine zipper kinase |
| MEK | Mitogen-activated protein kinase |
| MET | Mesenchymal Epithelial Transition |
| miR/miRNA | microRNA |
| MMP | Matrix metalloproteinase |
| MRE11 | Meiotic recombination 1 |
| mRNA | Messenger RNA |
| ncRNA | Non-coding RNA |
| N | Asparagine |
| NF-kB | Nuclear factor kappa B |
| NMR | Nuclear magnetic resonance spectroscopy |
| n-Ras | Neuroblastoma rat sarcoma virus |
| NRD | N-terminal repressor domain |
| NSCLC | Non-small cell lung cancer |
| NRFM | Negative regulators of FOXM1 |
| OS | Overall survival |
| PARP | Poly (ADP-ribose) polymerase |
| p27/Kip1 | Cyclin-Dependent Kinase Inhibitor 1B |
| PD1 | Programmed Cell Death Protein 1 |
| PD-L1 | Programmed Cell Death Ligand 1 |
| PVT1 | Plasmacytoma variant translocation 1 gene |
| PLK | Polo-like kinases |
| POI | Protein of interest |
| PPI | Protein–protein interaction |
| p-PKCδ | Phosphoprotein kinase Cδ |
| PR | Progesterone |
| PROTAC | Proteolysis-targeted chimera |
| PTEN | Phosphatase and Tensin Homolog |
| PTM | Post-translational modification |
| PVT1 | plasmacytoma variant translocation 1 gene |
| R | Arginine |
| RAD51 | RADiation sensitive protein 51 |
| RAF | Rapidly Accelerated Fibrosarcoma |
| Rb | Retinoblastoma protein |
| RCM-1 | Robert Costa Memorial drug-1 |
| RFC5 | Replication Factor C Subunit 5 |
| S | Serine |
| siRNA | Small interfering RNA |
| SLUG | Zinc finger protein SNAI2 |
| SMAD3 | Mothers against decapentaplegic homolog 3 |
| Snail | Zinc finger protein SNAI1 |
| Sox2 | SRY-Box Transcription Factor 2 |
| SRC | Src proto-oncogene |
| SRT-100 | Solanum incanum extract |
| STAT3 | Signal transducer and activator of transcription 3 |
| SUMO | Small Ubiquitin-like Modifier |
| T | Threonine |
| TAD | Transactivation domains |
| TMZ | Temozolomide |
| TNBC | Triple-negative breast cancer |
| TGF-β | Transforming Growth Factor Beta 1 |
| TP53 | Tumor Protein P53 |
| TPD | Targeted protein degradation |
| XIAP | X-linked inhibitor of apoptosis protein |
| XRCC1 | X-ray repair cross-complementing protein 1 |
| IBE2C | Ubiquitin-conjugating enzyme E2C |
| U87MG | Uppsala 87 Malignant Glioma |
| U373 | Uppsala 373 |
| USP7 | Ubiquitin Specific Peptidase 7 |
| USP21 | Ubiquitin-specific protease |
| VEGFA | Vascular endothelial growth factor A |
| VHL | Von Hippel–Lindau syndrome |
| WDR5 | WD repeat domain 5 |
| WNT | Wingless-related integration site |
| 5-FU | 5-fluorouracil |
| 5-HT7 | 5-hydroxytryptamine |